Biotechnology, Center for

 

Date of this Version

12-26-2022

Document Type

Article

Citation

Acta Biomaterialia 158 (2023) 493–509. https://doi.org/10.1016/j.actbio.2022.12.043

Comments

Open access.

Abstract

Effective antigen delivery facilitates antiviral vaccine success defined by effective immune protective re- sponses against viral exposures. To improve severe acute respiratory syndrome coronavirus-2 (SARS-CoV- 2) antigen delivery, a controlled biodegradable, stable, biocompatible, and nontoxic polymeric micro- sphere system was developed for chemically inactivated viral proteins. SARS-CoV-2 proteins encapsulated in polymeric microspheres induced robust antiviral immunity. The viral antigen-loaded microsphere sys- tem can preclude the need for repeat administrations, highlighting its potential as an effective vaccine.

Share

COinS